BARDA partners with Cue Health to develop a multiplex test to ...

WEB ANNOUNCEMENT ... BARDA is partnering with Cue Health to develop a point-of-care (POC) and home use, over-the-counter (OTC) Multiplex ...

Cue Health Awarded New $28 Million Federal Contract to Develop ...

“By expanding our successful partnership with BARDA, we're able to meet a critical health need by utilizing Cue's diagnostic platform to ...

Cue Health Awarded $28M to Develop Multiplex Respiratory Test

By expanding our successful partnership with BARDA, we're able to meet a critical health need by utilizing Cue's diagnostic platform to ...

Cue Health Awarded $28M BARDA Contract to Develop ... - 360Dx

Cue Health Awarded $28M BARDA Contract to Develop Multiplex Respiratory Test · To read the full story...

BARDA-Supported Multiplex Diagnostic Test for COVID-19, Flu, and ...

BARDA partners with Cue Health to develop a multiplex test to detect and differentiate influenza, RSV, and SARS-CoV-2 · READ ANNOUNCEMENT Next ...

Cue Health receives contract for multiplex test development

Cue Health has received a $28m Federal contract for the development of multiplex tests for both POC and over-the-counter applications.

BARDA provides funding to Cue Health Inc to support the diagnosis ...

On 2 August 2023, the Biomedical Advanced Research and Development Authority (BARDA) ... We're honored to be called upon once again to partner with ...

Cue Health wins $28M BARDA contract to develop rapid respiratory ...

... development of over-the-counter and point-of-care tests. In either setting, the multiplex test would be designed to help patients and healthcare ...

BARDA | BARDA is continuing its partnership with @cuehealth to ...

The test uses a nasal swab sample and the Cue Health ... The multiplex test will be submitted to ... health information and improve equitable testing access.

Cue Awarded $28M Contract - San Diego Business Journal

Print. Cue Health's molecular multiplex device tests for Flu A/B, RSV ... Cue Health's last awarded BARDA contract was in 2020, when BARDA helped ...

BARDA Awards up to $30M to Cue Health for Influenza, Respiratory ...

The firm anticipates that the award will accelerate the development of its over-the-counter and professional-use influenza and multiplex respiratory ...

Cue Health to Develop Omicron-Genotyping COVID-19 Test in ...

... Cue. "We are proud to partner with BARDA to develop this new test, which will help eliminate guesswork, provide more choices for patients, and strengthen ...

Cue Health awarded $13 million government contract to develop ...

“We have worked with the BARDA team for the past two years developing and testing a 20-minute, molecular influenza test designed for home and ...

Cue Health, HHS Partner to Develop Omicron Test

The San Diego-based biotech has worked with BARDA since 2018 and has received more than $43 million in potential funding for various research ...

David Tsay M.D., Ph.D. on LinkedIn: Cue Health Awarded New $28 ...

Exciting news of a new partnership with BARDA to develop a fast and accurate Over The Counter multiplex test for Influenza, COVID-19, ...

BARDA Diagnostics News - 360Dx

Roche, BARDA Partner to Develop Diagnostics for Traumatic Brain Injuries ... Cue Health Awarded $28M BARDA Contract to Develop Multiplex Respiratory Test.

Cue Health plans to develop omicron-genotyping Covid-19 test

“We are proud to partner with BARDA to develop this new test, which will help eliminate guesswork, provide more choices for patients, and ...

Tomer Stavitsky on LinkedIn: Cue Health wins $28M BARDA ...

... test reflects both impressive adaptability and the imperative of diversification in a volatile market. The development of a multiplex test that rapidly ...

BARDA support paves way for at-home flu tests - CIDRAP

BARDA said Cue Health is also developing its device to test for ... multiplex test to detect and differentiate between respiratory pathogens.

Cue Health - SEC.gov

... developing or launching additional tests for our Cue Health Monitoring System; ... Technical development for the Cue Influenza A/B + COVID-19 Multiplex test is ...